Stock fact sheet · data as of
The Joint Corp. (JYNT): fair value, margin of safety and Wheel Score
Healthcare · Medical - Care Facilities · United States · Blend
Is JYNT undervalued?
At 6.91 (close of 16 Oct 2026), JYNT trades 69% over the GLS average fair value of 4.08, with 1 of 8 models above the price. The stock earns none of the Wheel Score's Value points at this price. That is a statement about price against trailing fundamentals, not about the company's prospects - the Wall Street View and the Growth tab on the Quote page carry the forward numbers.
There is a wide gap between GLS Growth (0.7805) and Graham Growth (8.37). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
The nightly engine files JYNT under Blend.
Nine valuation models for JYNT
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 2.60 | -62% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 2.58 | -63% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 8.37 | +21% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 3.14 | -54% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 0.7805 | -89% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 6.51 | -6% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 5.69 | -18% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 2.96 | -57% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | 0.4385 | -94% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 20.00 | +189% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
The Joint Corp. scores 8 of 9 on the Piotroski F-score, the nine yes/no tests of profitability, leverage and efficiency on the latest annual accounts - a strong reading that passes the Sunday Scan's "6 or more" rule with room to spare. A GLS Moat score of 4.0/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.
Returns on capital are high - ROIC 17.0%, ROE 19.3%, ROA 4.8% - with debt at 0.13 times equity and a free-cash-flow yield of 4.3%.
The Joint Corp. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Royalty 55%, Advertising 25%, Technology Service 10% (quarter Q2 FY2026).
Institutional ownership scores 9/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 8 / 9 | ROIC | 17.0% |
|---|---|---|---|
| GLS Moat | 4.0 / 10 | ROE | 19.3% |
| Debt / equity | 0.13 | ROA | 4.8% |
| Free-cash-flow yield | 4.3% | Payout ratio | 0% |
| Institutions | 9 / 10 | Insiders · Congress | 10 · 5 / 10 |
Wheel Score 38: Weak
With a Wheel Score of 38 The Joint Corp. sits in the Weak band. The parts - Value 0/25, Health 18/20, Moat 6/15, Premium 8/20, Stability 6/20 - show where: Value (0/25) scores lowest.
Implied volatility is 108% on the near-the-money contracts 20-60 days out - above the 60% ceiling of the sweet spot. Premiums are large, but the Wheel Score tapers the Premium points (8 of 20) because volatility this high usually comes with a reason. Chain open interest is thin - 406 contracts across every expiry - so fills at a fair price are not guaranteed; a 30-45-day put may not exist at a usable strike.
Volume runs at 61k shares a day on a market cap of $98M, with a beta of 1.09; the Stability part of the Wheel Score gives that 6 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 0 / 25 | -69% margin of safety | |
| Health | 18 / 20 | Piotroski 8/9 | |
| Moat | 6 / 15 | moat 4.0/10 | |
| Premium | 8 / 20 | implied volatility 108% | |
| Stability | 6 / 20 | 61k shares/day, $98M cap, beta 1.09 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 5 Nov 2026 (after the close), 20 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Care Facilities
The 12 companies below are the closest to The Joint Corp. by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| AIRS AirSculpt Technologies, Inc. | 1.42 | - | - | 36Weak | $102M |
| PARK Park Dental Partners, Inc. Common Stock | 19.00 | 17,706.27 | +100% | 39No options | $90M |
| BTMD biote Corp. | 1.11 | 11.26 | +90% | 39No options | $49M |
| EUDA EUDA Health Holdings Limited | 15.49 | - | - | 31No options | $46M |
| KJFI Comjoyful International Company | 0.9740 | - | - | 31No options | $212M |
| AONC American Oncology Network, Inc. | 11.00 | - | - | 29No options | $322M |
| CCEL Cryo-Cell International, Inc. | 3.65 | 11.97 | +69% | 39No options | $29M |
| DCGO DocGo Inc. | 0.2820 | - | - | 40Weak | $28M |
| VMD Viemed Healthcare, Inc. | 9.69 | 14.75 | +34% | 77Good | $369M |
| SRTA Strata Critical Medical, Inc. | 4.28 | 11.39 | +62% | 45Weak | $379M |
| AUNA Auna S.A. | 5.30 | 29.73 | +82% | 39No options | $392M |
| CYH Community Health Systems, Inc. | 2.99 | 154.27 | +98% | 45Weak | $422M |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about JYNT
Is JYNT undervalued right now?
No: at 6.91 the stock trades 69% above the GLS average fair value of 4.08 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.
What is the Wheel Score of JYNT and what does it mean?
JYNT scores 38 out of 100 (Weak). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for JYNT?
4.08 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does The Joint Corp. report earnings next?
The next earnings report is due on 5 Nov 2026 (after the close), 20 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does JYNT have listed options, and how liquid are they?
Yes. The nightly snapshot found 62 listed contracts with 406 open interest across all expiries and implied volatility of 108% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.